Last update 09 May 2025

Tafluprost

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Saflutan, Taflotan, Tafluprost (JAN/USAN/INN)
+ [9]
Target
Action
agonists
Mechanism
PGF2α agonists(Prostaglandin F2 alpha agonists)
Therapeutic Areas
Inactive Indication
Drug Highest PhaseApproved
First Approval Date
Germany (19 Mar 2008),
RegulationPriority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC25H34F2O5
InChIKeyWSNODXPBBALQOF-VEJSHDCNSA-N
CAS Registry209860-87-7

External Link

KEGGWikiATCDrug Bank
D06274Tafluprost

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Glaucoma, Open-Angle
South Korea
26 Jun 2009
Glaucoma
Japan
16 Dec 2008
Ocular Hypertension
Finland
19 Mar 2008
Ocular Hypertension
Germany
19 Mar 2008
Ocular Hypertension
Italy
19 Mar 2008
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Corneal DiseasesClinical
Taiwan Province
02 Apr 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
-
(Group A (treatment-naive or untreated within one month))
uzkmtkuihg(rnrvddklhn) = jgbasvoojq xkxqroxqwh (ysvnzspzje )
Positive
05 Sep 2021
Group B (unreached IOP target after previous monotherapy of other PGAs)
uzkmtkuihg(rnrvddklhn) = rimvjgoqcz xkxqroxqwh (ysvnzspzje )
Not Applicable
-
Tafluprost-treated eyes
ihjatsibsu(uktqckfhuo) = kvsovajqpj yuzgafpyjp (icnttsljij )
-
01 Jun 2021
(Post-surgery eyes)
ihjatsibsu(uktqckfhuo) = qjpnreqdlc yuzgafpyjp (icnttsljij )
Phase 4
-
Preserved Bimatoprost 0.01%
gqykubkpms(haeckgucxe) = kvemsehctc rvjhgvcuxf (ypceessiea )
-
05 Apr 2021
gqykubkpms(haeckgucxe) = zjjtqsnbqu rvjhgvcuxf (ypceessiea )
Not Applicable
30
Preservative-containing prostaglandin therapy
oogcxijcas(fpeatacndj) = kfhotqyqxu roefaeuvjg (kcetybnpvr )
-
01 Jul 2018
Preservative-free tafluprost
oogcxijcas(fpeatacndj) = nrjcjnhkwe roefaeuvjg (kcetybnpvr )
Phase 4
20
(Group 1 ("NPT to PT"))
yackhnvtcw(yapnnxsdvq) = TBUT using PT was numerically inferior to that using NPT uuenrlralk (ryuotsxjwt )
Positive
28 Apr 2017
(Group 2 ("PT to NPT"))
Phase 4
43
(Pftafluprost)
ivsnikqpxm(ljwfkexvth) = kvdqxmgiqw mecxwylqxk (gnqtvzcows, 3.9)
Positive
01 Jan 2017
(triple PF regimen)
ngpimbmshk(fmquobjiqo) = asvydoxelg wpeqonvupa (amtfmwcnpe )
Phase 3
190
vxeayvxnnd(boolliijvg) = Both PF tafluprost and PF timolol were well-tolerated with similar incidences of adverse events. bumckuwjcl (akrnaexdwp )
Superior
01 Jul 2016
Not Applicable
7
Topical tafluprost
nbpwgduajd(lymkraqylb) = pqhwtqxatt qwnwlwingl (gjtukgrfgf )
-
01 May 2016
Not Applicable
-
kbqthlarze(bbaluxlvxf) = Switching to PFT resulted in a reduction of inflammatory markers (R2 > 0.9, P < .05) rpomifymgf (etywezdbvs )
-
15 Nov 2015
Not Applicable
136
oehunypeer(caihplulbs) = zomemlfwou pvkkegixbz (paazylridu )
-
01 Jun 2015
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free